The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Acurx Pharmaceuticals Inc shares valued at $25,000 were purchased by Scodari Joseph C on Jan 06 ’25. At $1.01 per share, Scodari Joseph C acquired 24,631 shares. The insider’s holdings grew to 27,708 shares worth approximately $20781.0 following the completion of this transaction.
Also, Sailer Carl purchased 24,631 shares, netting a total of over 25,000 in proceeds. Following the buying of shares at $1.01 each, the insider now holds 137,183 shares.
Before that, LUCI DAVID P had added 49,261 shares to its account. In a trade valued at $50,000, the President and CEO bought Acurx Pharmaceuticals Inc shares for $1.01 each. Upon closing the transaction, the insider’s holdings increased to 49,261 shares, worth approximately $0.82 million.
Analyzing ACXP Stock Performance
During the last five days, there has been a drop of approximately -7.74%. Over the course of the year, Acurx Pharmaceuticals Inc shares have dropped approximately -7.74%. Shares of the company reached a 52-week high of $1.2500 on 01/06/25 and a 52-week low of $0.6801 on 01/08/25. A 50-day SMA is recorded $1.2466, while a 200-day SMA reached $1.9180. Nevertheless, trading volume fell to 1.61 million shares from 1.18 million shares the previous day.
Support And Resistance Levels for Acurx Pharmaceuticals Inc (ACXP)
According to the 24-hour chart, there is a support level at 0.6774, which, if violated, would cause prices to drop to 0.6038. In the upper region, resistance lies at 0.8273. The next price resistance is at 0.9036. RSI (Relative Strength Index) is 38.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0371, which suggests the price will decrease in the coming days. Percent R is at 87.56%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
